{"title": "Impfungen bei rheumatischen Erkrankungen des Kindes- und Jugendalters", "author": "K Minden; M Niewerth; M Borte; W Singendonk; J -P Haas; Martina Niewerth", "url": "https://www.academia.edu/29395949/Impfungen_bei_rheumatischen_Erkrankungen_des_Kindes_und_Jugendalters", "hostname": "academia.edu", "description": "Impfungen bei rheumatischen Erkrankungen des Kindes- und Jugendalters", "sitename": "Springer Nature", "date": "2007-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Academia.edu uses cookies to personalize content, tailor ads and improve the user experience.\nBy using our site, you agree to our collection of information through the use of cookies.\nTo learn more, view our\n[Privacy Policy.](https://www.academia.edu/privacy)\nAcademia.edu no longer supports Internet Explorer.\nTo browse Academia.edu and the wider internet faster and more securely, please take a few seconds to\n[upgrade your browser](https://www.academia.edu/upgrade-browser).\n2007, Zeitschrift f\u00fcr Rheumatologie\n2004, Z Rheumatol\nFlugmedizin \u00b7 Tropenmedizin \u00b7 Reisemedizin - FTR\nIm Laufe des Studiums arbeitet man sich als Student durch so manches Fachbuch und versucht, das f\u00fcr sich \u00abpassende\u00bb Exemplar zu finden. Als p\u00e4diatrisch interessierte Studenten wurden wir w\u00e4hrend des Praktischen Jahres auf die \u00abPediatric Secrets\u00bb von Richard A. Polin und Mark F. Ditmar aufmerksam. Dieses Buch stellt im englischsprachigen Raum durch seine etwas ungew\u00f6hnliche Art, Wissen zu vermitteln, ein \u00e4u\u00dferst beliebtes P\u00e4diatriebuch dar. Auch wir hatten damit unser Lieblings-P\u00e4diatriebuch gefunden, das uns auch heute noch in der t\u00e4glichen Arbeit als wichtige Referenz und Nachschlagewerk dient. Das chinesische Sprichwort \u00abWer fragt, ist ein Narr f\u00fcr f\u00fcnf Minuten; wer nicht fragt, bleibt ein Narr f\u00fcr immer\u00bb stellen die Autoren den \u00abPediatric Secrets\u00bb voran und betonen damit, wie wichtig das st\u00e4ndige Fragen im klinischen Alltag und das kritische Hinterfragen des eigenen Wissensstandes f\u00fcr die medizinische Ausbildung ist. Die \u00abPediatric Secrets\u00bb m\u00f6chten und k\u00f6nnen ein Lehrbuch nicht e...\n2004, Monatsschrift Kinderheilkunde\n2005, GMS Health Technology Assessment\nThe European Agency for the Evaluation of Medicinal Products (EMEA) granted market authorisation to the heptavalent pneumococcal vaccine Prevenar (Wyeth) in the year 2001. The indication of Prevenar is the active immunisation of infants and young children under the age of two against invasive disease caused by Streptococcus pneumonia serotypes 4, 6B, 9V, 14, 18C, 19F and 23F. At the time of this study the German vaccination scheme advises the immunisation with Prevenar only for children at high risk. The objective of the study is first to determine the efficacy and effectiveness of the immunisation of all children with the heptavalent conjugated pneumococcal vaccine in Germany and second, whether a general recommendation for vaccination of all children would be cost-effective. A systematic literature search was performed in 29 relevant databases for the period of January 1999 to June 2004. Thus 1,884 articles were identified which were then assessed according to predefined selection...\n2016\n2009\n2013, Deutsche medizinische Wochenschrift (1946)\nMeasles is re-emerging in several developed countries because of suboptimal vaccination coverage. Health-care facilities play a crucial role in the transmission of measles infection. Nosocomial measles may contribute for an important part of cases in measles epidemics, especially in countries where measles is largely under control. The risk of acquiring measles is estimated to be 2 to 19 times higher for susceptible healthcare personnel (HCP) than for the general population. Measles vaccination of HCP should be included by all health care facilities as part of a strict occupational health program. All HCP should have documented evidence of measles immunity. Immunity against measles should be a prerequisite for working in areas where the most vulnerable patients are cared for. Both occupational and public health measures are needed to ensure that nosocomial measles should be comprehensively monitored and consistently prevented.\nLoading Preview\nSorry, preview is currently unavailable. You can download the paper by clicking the button above.\n2006, Der Internist\n2011\n2007, Z Gastroenterol\n2009, Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz\nUm die Wirksamkeit eines Impfprogrammes einsch\u00e4tzen zu k\u00f6nnen, ist nicht nur Wissen \u00fcber die Wirksamkeit eines Impfstoffes in der Anwendungsrealit\u00e4t wichtig, sondern \u2013 neben vielen weiteren Aspekten \u2013 auch \u00fcber die Epidemiologie der Krankheit, gegen die geimpft wird. So kann ermittelt werden, ob ein Impfprogramm so weit umgesetzt und akzeptiert wird, dass auch ein Effekt auf der Populationsebene sichtbar wird (Herdenimmunit\u00e4t). Momentan sind die in Deutschland verf\u00fcgbaren Routinedaten nicht ausreichend, um die Wirksamkeit von Impfprogrammen zu evaluieren. Daher m\u00fcssen zus\u00e4tzliche Surveillanceprogramme initiiert werden. In welcher Form diese Programme durchgef\u00fchrt werden m\u00fcssen, h\u00e4ngt in erster Linie von der H\u00e4ufigkeit der durch den Impfstoff zu verhindernden Erkrankung ab. Im vorliegenden Beitrag sollen die unterschiedlichen Anforderungen an Surveillanceprogramme f\u00fcr seltene und h\u00e4ufige Erkrankungen herausgearbeitet und anhand je eines Beispiels M\u00f6glichkeiten f\u00fcr deren Realisierung dargestellt werden. Als Beispiel f\u00fcr ein Surveillancesystem bei einer seltenen Erkrankung dient die Studie zur \u00dcberpr\u00fcfung der Wirksamkeit hexavalenter Kombinationsimpfstoffe mit Haemophilus-influenzae -Typ-b-Komponente, als Beispiel f\u00fcr ein Surveillancesystem bei einer h\u00e4ufigen Erkrankung dient das Varizellensentinel der Arbeitsgemeinschaft Masern und Varizellen. Diese und andere Surveillancesysteme zur \u00dcberpr\u00fcfung der Wirksamkeit von Impfprogrammen werden nicht oder nur zum Teil durch \u00f6ffentliche Mittel gef\u00f6rdert. Die m\u00f6glichen Limitationen anderweitiger finanzieller F\u00f6rderung werden anhand der genannten Studien diskutiert. To evaluate the effectiveness of vaccination programmes, it is not only important to know the effectiveness of the specific vaccine itself but also to have knowledge about the epidemiology of the corresponding vaccine-preventable disease. Only a high acceptance of a vaccination programme by the population will show an effect at the population level (herd immunity). At the moment, data routinely collected in Germany are not sufficient to evaluate the effectiveness of vaccination programmes. Hence, additional surveillance programmes have to be initialised. The frequency of the vaccine-preventable disease in the population under surveillance determines mainly the design of the surveillance. In this article we describe the different requirements for surveillance programmes for common as well as for rare vaccine-preventable diseases. An example for the latter will be the ESPED study on the effectiveness of hexavalent vaccines against Haemophilus influenzae type b, an example for the first will be the varicella sentinel of the Working Group on Measles and Varicella. Both surveillance programmes for evaluation of the effectiveness of the respective vaccination programme are financed only partly by the public funds. We discuss the possible limitations of a funding from other sources.\n2007, Zeitschrift f\u00fcr Gastroenterologie\n2008, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz\nVaccinations are among the most effective and cost-effective means to prevent serious infectious diseases. Actual vaccination rates, however, still fall short of their full potential to reduce morbidity and mortality both in industrialized and low-income countries. Therefore, strategies to increase immunization rates are ethically and economically mandated, raising the following ethical issue: To what extent is it ethically appropriate to restrict individual autonomy by compulsory immunization requirements in order to achieve a sufficient collective protection of the community? Restrictions of individual autonomy are ethically justified if the following five conditions are met: (1) proven benefit, (2) favourable benefit-risk-ratio, (3) acceptable cost-benefit ratio, (4) as little restrictions as possible and (5) fair and transparent decision procedures. Depending on how far these five criteria are met, different strengths of recommendation result for each specific immunization progr...\n2015, JDDG: Journal der Deutschen Dermatologischen Gesellschaft\n2011, Pharmazie in unserer Zeit\n2017, Arthritis und Rheuma\nSummary: It is dogmatically repeated that vaccines in general are one of the most important and effective health investments. Following this paradigm, health systems are compared and judged by vaccination coverage. It is not known, however, if general health is improved by vaccination campaigns for other than the targeted diseases. There are non-specific effects of vaccination which seem to be positive for live attenuated vaccines, but not for inactivated and adjuvanted vaccines for which some studies suggest deleterious effects. Research on the nonspecific effects of vaccination on morbidity and mortality in children is scarce. The rule is underreporting of adverse effects, lack of serious follow-up data and missing control groups considered unethical. Independent research could easily be financed through the tax (19 % VAT in Germany) imposed on vaccines.\n2012, Zeitschrift f\u00fcr Rheumatologie\nMonatsschrift Kinderheilkunde\n2008, Pharmazie in unserer Zeit\n2018, Managed care\nAsthma is a common chronic respiratory disease affecting nearly 8% of the U.S. POPULATION It results in substantially higher direct and indirect costs as well as an increased mortality risk and poorer quality of life, particularly among patients with difficult-to-control asthma. While several physiologic tests, including spirometry, are typically used to diagnose and characterize asthma, they do not provide the sensitivity and specificity required to accurately reflect the underlying heterogeneous inflammatory pathways. Fractional exhaled nitric oxide (FeNO) is a validated, noninvasive biomarker for T2-driven (i.e., allergic) airway inflammation that correlates with sputum eosinophils at or greater than 3% across various asthma phenotypes. Its use as a biomarker in asthma is well supported by numerous peer-reviewed articles and guidelines. There is also evidence that its use in clinical settings for patients with uncontrolled asthma is cost effective, given its ability to improve th...\n2015, Das Gesundheitswesen\nAllergo Journal\n2005, Ophthalmologe\nMPH thesis\nWiener klinische Wochenschrift\nZusammenfassung Mitglieder der \u00d6sterreichischen Gesellschaft f\u00fcr Pneumologie (\u00d6GP) beschreiben die erwartete Entwicklung der respiratorischen Gesundheit und zeigen Wege einer patientenorientierten und kosteneffizienten Versorgung f\u00fcr \u00d6sterreich auf. Methoden: Im November 2017 trifft sich eine Gruppe von respiratorisch t\u00e4tigen \u00c4rzten, Pflegekr\u00e4ften und Physiotherapeuten, gemeinsam mit Vertretern von Selbsthilfe-Gruppen und Experten f\u00fcr Gesundheitsentwicklung, um die Themen Rahmenbedingungen f\u00fcr Lungengesundheit, Asthma und Allergie, COPD, Mukoviszidose und andere Krankheitsbilder der p\u00e4diatrischen Pneumologie, Infektionen in der Pneumologie, Schlafbezogene Atemst\u00f6rungen, Interventionelle Pneumologie, Thorakale Onkologie, und Orphan Diseases zu bearbeiten. Ergebnisse: Respiratorische Erkrankungen sind extrem h\u00e4ufig und werden sehr oft durch individuelles Fehlverhalten (Zigarettenrauchen, \u00dcberern\u00e4hrung, k\u00f6rperliche Inaktivit\u00e4t) verursacht. Zudem wird f\u00fcr respiratorische Erkrankungen ei...\n2012, Klinische P\u00e4diatrie\n2015, Augsburger Volkskundliche Nachrichten\n2008, Wiener klinische Wochenschrift\n2016, Deutsches A\u0308rzteblatt international\nOptimizing the emergency medical care chain might shorten the time to treatment of patients with ST-elevation myocardial infarction (STEMI). The initial care by a physician, and, in particular, correct ECG interpretation, are critically important factors. From 1999 onward, data on the care of patients with myocardial infarction have been recorded and analyzed in the Berlin Myocardial Infarction Registry. In the First Medical Contact Study, data on initial emergency medical care were obtained on 1038 patients who had been initially treated by emergency physicians in 2012. Their pre-hospital ECGs were re-evaluated in a blinded fashion according to the criteria of the European Society of Cardiology. The retrospective re-evaluation of pre-hospital ECGs revealed that 756 of the 1038 patients had sustained a STEMI. The emergency physicians had correctly diagnosed STEMI in 472 patients (62.4%), and they had correctly diagnosed ventricular fibrillation in 85 patients (11.2%); in 199 patient...\nP\u00e4diatrie & P\u00e4dologie\nChild public health. A missing link in primary care? Abstract There is significant need for improvement in the primary care of children and adolescents in Austria: overfilled hospital emergency rooms outside primary physicians\u2019 office hours, fragmentation of care and inadequate pediatric knowledge by primary care providers, a focus that is too strong on hospitals and physicians, and a lack of health literacy in dealing with health issues and with health care facilities on the side of the children and their families. It is suggested that more specific know-how be developed concerning public health, e.g., health promotion, prevention, and child-centered, easily accessible primary care by multidisciplinary health care teams with special competence in pediatrics. This can relieve the burden in hospital emergency rooms, improve the outcomes for the children, and reduce costs. The principles of primary care as presented by the WHO and the development of health literacy play an important role.KeywordsPediatric primary care \u00b7 Health literacy \u00b7 Health promotion \u00b7 Child public health \u00b7 Health servicesF\n2010, Addiction\n2005, Zeitschrift f\u00fcr Rheumatologie\n2011, Monatsschrift Kinderheilkunde\n2008, Wiener Klinische Wochenschrift\nIn 1988 the 41th World Health Assembly declared polio to be worldwide eradicated until the year 2000. Although this ambitious aim could not be reached completely, the yearly worldwide incidence was reduced by 99% and three WHO-Regions were declared polio-free (Americans, West Pacific, Europe). To maintain this status the following measures have to be carried out: polio vaccination, enterovirus surveillance, AFP-surveillance, quality control of laboratories and notification of labs keeping stocks of polio wildvirus. Especially after the Second World War Austria faced severe polio epidemics and thus general and free of charge polio vaccination for children and young adults up to 21 years was started in winter 1961/62 by the Austrian Ministry of Health (MoH). Immediately the yearly incidence dropped from 3.65/100.000 (n = 292) in 1961 to 0.1/100.000 (n = 8) in 1962. Since 1998 all mandatory national measures according the WHO polio eradication programme have been performed. Despite the worldwide success of the programme there are currently still four countries with endemic polio and since November 2006 eleven further countries have faced epidemics due to imported cases. Therefore the 60th World Health Assembly in 2007 again pointed to the threat of failing worldwide polio eradication. Currently the Global Polio Eradication Initiative (GPEI) works intensively with the concerned countries to fight against this development. Die WHO hat anl\u00e4sslich ihrer 41. Vollversammlung im Jahr 1988 das Ziel formuliert, die Poliomyelitis bis zum Jahr 2000 weltweit zu eliminieren. Dieses Ziel wurde zwar nicht vollst\u00e4ndig erreicht, aber es konnte die weltweite j\u00e4hrliche Inzidenz um 99% reduziert werden und drei WHO-Regionen (Amerika, Westpazifik, Europa) wurden f\u00fcr poliofrei erkl\u00e4rt. Um diesen Status zu erhalten, sind folgende Ma\u00dfnahmen regelm\u00e4\u00dfig durchzuf\u00fchren: Polio-Durchimpfung, Enterovirus-\u00dcberwachung, AFP-Surveillance, Labor-Qualit\u00e4tskontrolle und Notifikation aller Labors, die Poliovirus lagern. \u00d6sterreich war insbesondere in der Nachkriegszeit von schweren Polio-Epidemien betroffen und f\u00fchrte im Impfwinter 1961/62 als eines der ersten L\u00e4nder weltweit die fl\u00e4chendeckende und kostenlose Oral-Polioimpfung f\u00fcr Kinder, Jugendliche und Erwachsene bis zum 21. LJ ein, was sich unmittelbar in drastisch reduzierter j\u00e4hrlicher Inzidenz (I) niederschlug (1961: n = 292; I: 3.65/100.000; 1962: n = 8; I: 0.1/100.000). Der letzte Poliofall trat im Jahr 1980 auf. Seit 1998 werden zus\u00e4tzlich alle notwendigen nationalen Ma\u00dfnahmen des Polio-Eradikationsprogrammes vollst\u00e4ndig umgesetzt. Trotz der weltweiten Erfolge ist Polio noch in vier L\u00e4ndern endemisch, und es traten zus\u00e4tzlich seit November 2006 in elf L\u00e4ndern Ausbr\u00fcche nach Neu-Einschleppung auf. Die WHO wies daher bei der 60. World Health Assembly 2007 neuerlich auf die immanente Gef\u00e4hrdung des Polio-Eradikationsprogrammes hin und arbeitet im Rahmen der Global Polio Eradication Initiative (GPEI) intensiv mit den betroffenen L\u00e4ndern an spezifischen Bek\u00e4mpfungsma\u00dfnahmen.\n2006, Monatsschrift Kinderheilkunde\n2005, Die Rehabilitation\n2005, Pneumologie (Stuttgart, Germany)\n2010, Pneumologie (Stuttgart, Germany)\nInfections are frequent and important causes of exacerbations in patients with COPD. This article reviews underlying mechanisms and therapeutic consequences. A complex interaction exists between COPD, co-morbidities, physical inactivity and systemic inflammation. The components of the postulated chronic inflammatory systemic syndrome need to be identified in more detail; physical inactivity seems to be the least common denominator. The patient's adaptive and innate immune systems play a role for the pathogenesis of infections. When interpreting positive bacterial cultures, it is important to differentiate between colonisation and infection. The impact of viral infections in COPD exacerbation needs further clarification, including the task to distinguish acute infection from viral persistence. Community acquired pneumonias pose a special risk for patients with COPD. Clinical scores and procalcitonin serum concentrations can support decisions on whether or not to start antibiotic ...\n2002\n2010, Der Internist\nMonatsschrift Kinderheilkunde\n2006, Clinical research in cardiology : official journal of the German Cardiac Society\nA recent survey conducted by the publicly funded Competence Network Sepsis (Sep- Net) reveals that severe sepsis and/or septic shock occurs in 75,000 inhabitants (110 out of 100,000) and sepsis in 79,000 inhabitants (116 out of 100,000) in Germany annually. This illness is responsible for approx. 60,000 deaths and ranges as the third most frequent cause of death after acute myocardial infarction. Direct costs for the intensive care of patients with severe sepsis alone amount to approx. 1.77 billion euros, which means that about 30% of the budget in intensive care is used to treat severe sepsis. However, until now German guidelines for the diagnosis and therapy of severe sepsis did not exist. Therefore, the German Sepsis Society initiated the development of guidelines which are based on international recommendations by the International Sepsis Forum (ISF) and the Surviving Sepsis Campaign (SSC) and take into account the structure and organisation of the German health care system. Pri...", "language": null, "image": "http://a.academia-assets.com/images/open-graph-icons/fb-paper.gif", "pagetype": "article", "links": ["https://www.academia.edu/privacy", "https://www.academia.edu/upgrade-browser", "javascript:void(0)", "https://www.academia.edu/signup", "https://www.academia.edu/", "https://www.academia.edu/login", "https://www.academia.edu/signup", "https://www.academia.edu/login", "https://www.academia.edu/signup", "https://www.academia.edu/Jobs", "https://www.academia.edu/about", "https://www.academia.edu/press", "https://medium.com/@academia", "https://www.academia.edu/Directory/People", "https://www.academia.edu/Directory/Papers", "https://www.academia.edu/terms", "https://www.academia.edu/privacy", "https://www.academia.edu/copyright", "https://www.academia.edu/hiring", "https://support.academia.edu/", "https://www.academia.edu/attachments/49836365/download_file?st=MTY5ODQ0MjcwNiwyMTcuMjM4LjEzNi4xNzYs&s=swp-splash-paper-cover", "https://www.academia.edu/attachments/49836365/download_file?st=MTY5ODQ0MjcwNiwyMTcuMjM4LjEzNi4xNzYs&s=swp-splash-paper-cover", "https://independent.academia.edu/WSingendonk", "https://independent.academia.edu/MartinaNiewerth", "https://www.academia.edu/23727343/Evidenzbasierter_Einsatz_von_Methotrexat_bei_Kindern_mit_rheumatischen_Erkrankungen", "https://independent.academia.edu/TimNiehues", "https://www.academia.edu/23727343/Evidenzbasierter_Einsatz_von_Methotrexat_bei_Kindern_mit_rheumatischen_Erkrankungen", "https://www.academia.edu/63594493/Reiseimpfungen_Hinweise_und_Empfehlungen", "https://independent.academia.edu/ClaraSchlaich", "https://www.academia.edu/63594493/Reiseimpfungen_Hinweise_und_Empfehlungen", "https://www.academia.edu/28997799/Fragen_und_Antworten_zur_P%C3%A4diatrie_Pediatric_Secrets_", "https://independent.academia.edu/EvelineStaub", "https://www.academia.edu/28997799/Fragen_und_Antworten_zur_P%C3%A4diatrie_Pediatric_Secrets_", "https://www.academia.edu/17519648/Varizellen_und_Varizellenimpfung", "https://independent.academia.edu/MKnuf", "https://www.academia.edu/17519648/Varizellen_und_Varizellenimpfung", "https://www.academia.edu/43510029/Lob_f%C3%BCr_Millers_Review_of_Critical_Vaccine_Studies_400_wichtige_wissenschaftliche_Papiere_zusammengefasst_f%C3%BCr_Eltern_und_Forscher", "https://independent.academia.edu/PeterNordmann", "https://www.academia.edu/43510029/Lob_f%C3%BCr_Millers_Review_of_Critical_Vaccine_Studies_400_wichtige_wissenschaftliche_Papiere_zusammengefasst_f%C3%BCr_Eltern_und_Forscher", "https://www.academia.edu/74032121/Effectiveness_and_cost_effectiveness_of_general_immunisation_of_infants_and_young_children_with_the_heptavalent_conjugated_pneumococcal_vaccine", "https://independent.academia.edu/epichlbauer", "https://www.academia.edu/74032121/Effectiveness_and_cost_effectiveness_of_general_immunisation_of_infants_and_young_children_with_the_heptavalent_conjugated_pneumococcal_vaccine", "https://www.academia.edu/73074725/Leitlinie_zur_Abkl%C3%A4rung_und_Vorbeugung_von_Infektionskrankheiten_und_Aktualisierung_des_Impfschutzes_bei_asymptomatischen_asylsuchenden_Kindern_und_Jugendlichen_in_der_Schweiz", "https://unibasel.academia.edu/NicoleRitz", "https://www.academia.edu/73074725/Leitlinie_zur_Abkl%C3%A4rung_und_Vorbeugung_von_Infektionskrankheiten_und_Aktualisierung_des_Impfschutzes_bei_asymptomatischen_asylsuchenden_Kindern_und_Jugendlichen_in_der_Schweiz", "https://www.academia.edu/23103453/Novel_vaccination_concepts_on_the_basis_of_modern_insights_into_immunology_Neue_Impfstoffkonzepte_auf_Basis_moderner_Erkenntnisse_der_Immunologie", "https://independent.academia.edu/AlexanderVonGabain", "https://www.academia.edu/23103453/Novel_vaccination_concepts_on_the_basis_of_modern_insights_into_immunology_Neue_Impfstoffkonzepte_auf_Basis_moderner_Erkenntnisse_der_Immunologie", "https://www.academia.edu/16477529/_Nosocomial_measles_infections_", "https://independent.academia.edu/SabineWicker", "https://www.academia.edu/16477529/_Nosocomial_measles_infections_", "https://www.academia.edu/57235637/Osteosarkom_Kurzinformation_", "https://independent.academia.edu/GescheTallen", "https://www.academia.edu/57235637/Osteosarkom_Kurzinformation_", "https://www.academia.edu/53966138/Der_internistische_Check_up", "https://independent.academia.edu/EBattegay", "https://www.academia.edu/53966138/Der_internistische_Check_up", "https://www.academia.edu/68137880/Aktualisierung_der_S3_Leitlinie_zur_Prophylaxe_Diagnostik_und_Therapie_der_Hepatitis_B_Virusinfektion_AWMF_Register_Nr_021_011_Prophylaxis_Diagnosis_and_Therapy_of_Hepatitis_B_Virus_Infection", "https://independent.academia.edu/WolfgangJilg", "https://www.academia.edu/68137880/Aktualisierung_der_S3_Leitlinie_zur_Prophylaxe_Diagnostik_und_Therapie_der_Hepatitis_B_Virusinfektion_AWMF_Register_Nr_021_011_Prophylaxis_Diagnosis_and_Therapy_of_Hepatitis_B_Virus_Infection", "https://www.academia.edu/68137595/Prophylaxe_Diagnostik_und_Therapie_der_Hepatitis_B_Virus_HBV_Infektion", "https://independent.academia.edu/WolfgangJilg", "https://www.academia.edu/68137595/Prophylaxe_Diagnostik_und_Therapie_der_Hepatitis_B_Virus_HBV_Infektion", "https://www.academia.edu/4845557/Durchf%C3%BChrung_von_Surveillanceprogrammen_zur_%C3%9Cberpr%C3%BCfung_der_Wirksamkeit_von_Impfprogrammen_am_Beispiel_von_Haemophilus_influenzae_Typ_b_und_Varizellen", "https://independent.academia.edu/DassK", "https://www.academia.edu/4845557/Durchf%C3%BChrung_von_Surveillanceprogrammen_zur_%C3%9Cberpr%C3%BCfung_der_Wirksamkeit_von_Impfprogrammen_am_Beispiel_von_Haemophilus_influenzae_Typ_b_und_Varizellen", "https://www.academia.edu/68137767/Prophylaxis_Diagnosis_and_Therapy_of_Hepatitis_B_Virus_HBV_Infection_The_German_Guidelines_for_the_Management_of_HBV_Infection", "https://independent.academia.edu/WolfgangJilg", "https://www.academia.edu/68137767/Prophylaxis_Diagnosis_and_Therapy_of_Hepatitis_B_Virus_HBV_Infection_The_German_Guidelines_for_the_Management_of_HBV_Infection", "https://www.academia.edu/22272685/_Vaccination_programs_between_individual_autonomy_and_common_welfare_", "https://independent.academia.edu/GeorgMarckmann", "https://www.academia.edu/22272685/_Vaccination_programs_between_individual_autonomy_and_common_welfare_", "https://www.academia.edu/56170444/Leitlinie_Neurodermitis_atopisches_Ekzem_atopische_Dermatitis_", "https://uni-giessen.academia.edu/UweGieler", "https://www.academia.edu/56170444/Leitlinie_Neurodermitis_atopisches_Ekzem_atopische_Dermatitis_", "https://www.academia.edu/68137744/Impfstoffe_gegen_die_Virushepatitiden_A_bis_E_Was_haben_sie_bewirkt_was_k%C3%B6nnen_sie_bewirken", "https://independent.academia.edu/WolfgangJilg", "https://www.academia.edu/68137744/Impfstoffe_gegen_die_Virushepatitiden_A_bis_E_Was_haben_sie_bewirkt_was_k%C3%B6nnen_sie_bewirken", "https://www.academia.edu/61501816/Harmonisierung_der_Diagnostik_und_Therapie_der_systemischen_juvenilen_idiopathischen_Arthritis_in_Deutschland", "https://independent.academia.edu/JPHaas", "https://www.academia.edu/61501816/Harmonisierung_der_Diagnostik_und_Therapie_der_systemischen_juvenilen_idiopathischen_Arthritis_in_Deutschland", "https://www.academia.edu/34890106/Das_Impfparadogma_und_m%C3%B6gliche_Auswege_The_Vaccination_Paradogma_and_Feasible_Solutions", "https://independent.academia.edu/StephanHeinrichNolte", "https://www.academia.edu/34890106/Das_Impfparadogma_und_m%C3%B6gliche_Auswege_The_Vaccination_Paradogma_and_Feasible_Solutions", "https://www.academia.edu/61501789/Physiotherapie_bei_der_juvenilen_idiopathischen_Arthritis", "https://independent.academia.edu/JPHaas", "https://www.academia.edu/61501789/Physiotherapie_bei_der_juvenilen_idiopathischen_Arthritis", "https://www.academia.edu/70695798/Abstracts_2019_der_GNPI_und_DGPI", "https://independent.academia.edu/CVonKaisenberg", "https://www.academia.edu/70695798/Abstracts_2019_der_GNPI_und_DGPI", "https://www.academia.edu/70122702/Impfskeptiker_Impfgegner_Von_einer_anderen_Realit%C3%A4t_im_Internet", "https://independent.academia.edu/WolfgangMaurerDDr", "https://www.academia.edu/70122702/Impfskeptiker_Impfgegner_Von_einer_anderen_Realit%C3%A4t_im_Internet", "https://www.academia.edu/73493422/A_Review_of_the_Utility_and_Cost_Effectiveness_of_Monitoring_Fractional_Exhaled_Nitric_Oxide_FeNO_in_Asthma_Management", "https://independent.academia.edu/ArnoldRenee", "https://www.academia.edu/73493422/A_Review_of_the_Utility_and_Cost_Effectiveness_of_Monitoring_Fractional_Exhaled_Nitric_Oxide_FeNO_in_Asthma_Management", "https://www.academia.edu/63172009/Gesundheitsbericht_der_Hansestadt_Rostock_2013", "https://hs-nb.academia.edu/ThomasElkeles", "https://www.academia.edu/63172009/Gesundheitsbericht_der_Hansestadt_Rostock_2013", "https://www.academia.edu/57526080/Praktischer_Umgang_mit_allergischen_Reaktionen_auf_COVID_19_Impfstoffe", "https://independent.academia.edu/KarlChristianBergmann", "https://www.academia.edu/57526080/Praktischer_Umgang_mit_allergischen_Reaktionen_auf_COVID_19_Impfstoffe", "https://www.academia.edu/21511791/47_Erkrankungen_der_Erythrozyten", "https://independent.academia.edu/EbertSebastian", "https://www.academia.edu/21511791/47_Erkrankungen_der_Erythrozyten", "https://www.academia.edu/68821726/Uveitis_in_conjunction_with_rheumatological_diseases_in_childhood", "https://independent.academia.edu/UPleyer", "https://www.academia.edu/68821726/Uveitis_in_conjunction_with_rheumatological_diseases_in_childhood", "https://www.academia.edu/2210809/Ethische_Implikation_bei_der_Bek%C3%A4mpfung_von_Infektionskrankheiten_Das_Beispiel_der_Impf_Priorisierung_in_Berlin_w%C3%A4hrend_derH1N1_Pandemie", "https://independent.academia.edu/JasperLittmann", "https://www.academia.edu/2210809/Ethische_Implikation_bei_der_Bek%C3%A4mpfung_von_Infektionskrankheiten_Das_Beispiel_der_Impf_Priorisierung_in_Berlin_w%C3%A4hrend_derH1N1_Pandemie", "https://www.academia.edu/64231238/Masterplan_2025_der_%C3%96sterreichischen_Gesellschaft_f%C3%BCr_Pneumologie_%C3%96GP_die_erwartete_Entwicklung_und_Versorgung_respiratorischer_Erkrankungen_in_%C3%96sterreich", "https://independent.academia.edu/MeinhardKneussl", "https://www.academia.edu/64231238/Masterplan_2025_der_%C3%96sterreichischen_Gesellschaft_f%C3%BCr_Pneumologie_%C3%96GP_die_erwartete_Entwicklung_und_Versorgung_respiratorischer_Erkrankungen_in_%C3%96sterreich", "https://www.academia.edu/13592328/Leitlinie_der_P%C3%A4diatrische_Arbeitsgemeinschaft_AIDS_PAAD_e_V_zur_antiretroviralen_Therapie_bei_HIV_infizierten_Kindern_und_Jugendlichen_2011_", "https://independent.academia.edu/CorneliaFeiternasperling", "https://www.academia.edu/13592328/Leitlinie_der_P%C3%A4diatrische_Arbeitsgemeinschaft_AIDS_PAAD_e_V_zur_antiretroviralen_Therapie_bei_HIV_infizierten_Kindern_und_Jugendlichen_2011_", "https://www.academia.edu/27206883/_Der_schnelle_Tod_der_grausamen_Krankheit_Die_Bek%C3%A4mpfung_der_Kinderl%C3%A4hmung_in_Bayern_1950_1980_Augsburger_Volkskundliche_Nachrichten_40_1_2015_57_85", "https://emory.academia.edu/AlexanderCors", "https://www.academia.edu/27206883/_Der_schnelle_Tod_der_grausamen_Krankheit_Die_Bek%C3%A4mpfung_der_Kinderl%C3%A4hmung_in_Bayern_1950_1980_Augsburger_Volkskundliche_Nachrichten_40_1_2015_57_85", "https://www.academia.edu/26918642/WHO_Eradikationsprogramm_f%C3%BCr_Poliomyelitis_Status_quo_und_Umsetzung_in_%C3%96sterreich", "https://independent.academia.edu/ReinhildStrauss", "https://www.academia.edu/26918642/WHO_Eradikationsprogramm_f%C3%BCr_Poliomyelitis_Status_quo_und_Umsetzung_in_%C3%96sterreich", "https://www.academia.edu/49797382/The_Emergency_Medical_Care_of_Patients_With_Acute_Myocardial_Infarction", "https://independent.academia.edu/MartinStockburger", "https://www.academia.edu/49797382/The_Emergency_Medical_Care_of_Patients_With_Acute_Myocardial_Infarction", "https://www.academia.edu/21174824/Child_Public_Health", "https://meduniwien.academia.edu/LillyDamm", "https://www.academia.edu/21174824/Child_Public_Health", "https://www.academia.edu/15282221/Child_Public_Health_Ein_missing_link_in_der_Prim%C3%A4rversorgung", "https://meduniwien.academia.edu/LillyDamm", "https://www.academia.edu/15282221/Child_Public_Health_Ein_missing_link_in_der_Prim%C3%A4rversorgung", "https://www.academia.edu/75468189/The_Good_the_Bad_and_the_Ugly", "https://surrey.academia.edu/TheofanisExadaktylos", "https://www.academia.edu/75468189/The_Good_the_Bad_and_the_Ugly", "https://www.academia.edu/29395948/Transition_Clinic_", "https://independent.academia.edu/MartinaNiewerth", "https://www.academia.edu/29395948/Transition_Clinic_", "https://www.academia.edu/18015219/Transkutane_Applikationen_bei_Impfungen_und_Immuntherapien", "https://independent.academia.edu/ThomasK%C3%BCndig", "https://www.academia.edu/18015219/Transkutane_Applikationen_bei_Impfungen_und_Immuntherapien", "https://www.academia.edu/50219666/Rheuma_bei_Kindern_und_Jugendlichen", "https://meduni-graz.academia.edu/BLeeb", "https://www.academia.edu/50219666/Rheuma_bei_Kindern_und_Jugendlichen", "https://www.academia.edu/10464253/WHO_Polio_Eradication_Programme_Status_quo_and_implementation_in_Austria", "https://independent.academia.edu/HubertHrabcik", "https://www.academia.edu/10464253/WHO_Polio_Eradication_Programme_Status_quo_and_implementation_in_Austria", "https://www.academia.edu/23727318/Empfehlungen_zur_antiretroviralen_Therapie_bei_HIV_infizierten_Kindern", "https://independent.academia.edu/TimNiehues", "https://www.academia.edu/23727318/Empfehlungen_zur_antiretroviralen_Therapie_bei_HIV_infizierten_Kindern", "https://www.academia.edu/24902151/Die_Rolle_von_Viren_bei_tiefen_Atemwegsinfektionen_des_Erwachsenen", "https://healthfoodinnovationmanagement.academia.edu/GernotRohde", "https://www.academia.edu/24902151/Die_Rolle_von_Viren_bei_tiefen_Atemwegsinfektionen_des_Erwachsenen", "https://www.academia.edu/32148985/Patientennahe_Assessmentinstrumente_in_der_deutschsprachigen_Rehabilitationsforschung_Aktuelle_Entwicklungen_aus_dem_F%C3%B6rderschwerpunkt_Rehabilitationswissenschaften_", "https://evh-bochum.academia.edu/ChristianZwingmann", "https://www.academia.edu/32148985/Patientennahe_Assessmentinstrumente_in_der_deutschsprachigen_Rehabilitationsforschung_Aktuelle_Entwicklungen_aus_dem_F%C3%B6rderschwerpunkt_Rehabilitationswissenschaften_", "https://www.academia.edu/59447902/_S3_guideline_on_ambulant_acquired_pneumonia_and_deep_airway_infections_", "https://independent.academia.edu/TobiasWelte", "https://www.academia.edu/59447902/_S3_guideline_on_ambulant_acquired_pneumonia_and_deep_airway_infections_", "https://www.academia.edu/59447916/_COPD_and_infection_", "https://independent.academia.edu/TobiasWelte", "https://www.academia.edu/59447916/_COPD_and_infection_", "https://www.academia.edu/25855373/Untersuchungen_zur_Compliance_und_Vertr%C3%A4glichkeit_der_Sulfasalazin_Therapie_bei_rheumatoider_Arthritis_und_seronegativen_Spondylarthropathien", "https://hm.academia.edu/HerbertPlischke", "https://www.academia.edu/25855373/Untersuchungen_zur_Compliance_und_Vertr%C3%A4glichkeit_der_Sulfasalazin_Therapie_bei_rheumatoider_Arthritis_und_seronegativen_Spondylarthropathien", "https://www.academia.edu/59447419/Pr%C3%A4vention_und_Nachsorge_der_Sepsis", "https://independent.academia.edu/TobiasWelte", "https://www.academia.edu/59447419/Pr%C3%A4vention_und_Nachsorge_der_Sepsis", "https://www.academia.edu/71347100/Die_intrazerebrale_Gentherapie_des_Aromatischen_L_Aminos%C3%A4ure_Decarboxylase_Mangels_mit_Eladocagene_exuparvovec", "https://independent.academia.edu/KarlKiening", "https://www.academia.edu/71347100/Die_intrazerebrale_Gentherapie_des_Aromatischen_L_Aminos%C3%A4ure_Decarboxylase_Mangels_mit_Eladocagene_exuparvovec", "https://www.academia.edu/16403227/_Diagnosis_and_therapy_of_sepsis_", "https://independent.academia.edu/GKreymann", "https://www.academia.edu/16403227/_Diagnosis_and_therapy_of_sepsis_", "https://www.academia.edu/Documents/in/Clinical_Sciences?f_loswp=29395949", "https://www.academia.edu/about", "https://www.academia.edu/press", "https://medium.com/academia", "https://www.academia.edu/Directory/People", "https://www.academia.edu/Directory/Papers", "https://www.academia.edu/topics", "https://www.academia.edu/Jobs", "https://www.academia.edu/hiring", "https://support.academia.edu/", "https://www.academia.edu/Documents/in/Physics", "https://www.academia.edu/Documents/in/Chemistry", "https://www.academia.edu/Documents/in/Biology", "https://www.academia.edu/Documents/in/Health_Sciences", "https://www.academia.edu/Documents/in/Ecology", "https://www.academia.edu/Documents/in/Earth_Sciences", "https://www.academia.edu/Documents/in/Cognitive_Science", "https://www.academia.edu/Documents/in/Mathematics", "https://www.academia.edu/Documents/in/Computer_Science", "https://www.academia.edu/terms", "https://www.academia.edu/privacy", "https://www.academia.edu/copyright"]}